Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 301–400 of 978
Kovell, L. C., Juraschek, S. P., & Russell, S. D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132228 · Cited by 33
Chan, J. C. N., Ozaki, R., Luk, A. O. Y., Kong, A. P. S., Ronald, C. W., Chow, F. C. C., Wong, P., Wong, R. Y. M., Chung, H. H. Y., Chiu, C., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(14)70733-8 · Cited by 34
Gabert, R., Thomson, B., Gakidou, E. E., & Roth, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159227 · Cited by 32
“[3,4] Without high-quality data on where people at highest risk from diabetes actually live, interventions are tested across broader areas with lower average risk, which in turn leads to negative results or minimal measured effect sizes for these trials.”
BackgroundEsteghamati, A., Ismail‐Beigi, F., Khaloo, P., Moosaie, F., Alemi, H., Mansournia, M. A., Afarideh, M., Molla, G. J., Ghadimi, T., Shadnoush, M., et al. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.07.002 · Cited by 35
Lee, D. Y., Park, J., Choi, D., Ahn, H.-Y., Park, S.-W., & Park, C.-Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-22034-0 · Cited by 31
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort
Mirani, M., Favacchio, G., Serone, E., Lucisano, G., Rossi, M. C., & Berra, C. C. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.003 · Cited by 31
Malta, D. C., Iser, B. P. M., Chueiri, P. S., Stopa, S. R., Szwarcwald, C. L., Schmidt, M. I., & Duncan, B. B. (2015) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-5497201500060003 · Cited by 31
Epidemiology of Diabetes in Adults Aged 35 and Older from Shanghai, China.
Ruan, Y., Yan, Q. H., Xu, J. Y., Yang, Q. D., Yao, H. H., Li, R., & Shi, Y. (2016) · PubMed · doi:10.3967/bes2016.053 · Cited by 31
Ishii, H., Shin, H., Tosaki, T., Haga, T., Nakajima, Y., Shiraiwa, T., Watanabe, N., Koizumi, M., Nakajima, H., Okada, S., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0414-4 · Cited by 34
Uppal, T. S., Chehal, P. K., Fernandes, G. F., HAW, J. S., Shah, M. K., Turbow, S. D., Rajpathak, S. N., Narayan, K. M. V., & Ali, M. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13867 · Cited by 37
Self-citationIntradermal Insulin Delivery: A Promising Future for Diabetes Management
Hultström, M., Roxhed, N., & Nordquist, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814530060 · Cited by 32
“However, even adequate glycemic control is difficult to achieve for a large number of patients.(7) This can be traced to difficult to regulate disease in some patients, but in the majority it is tied to poor adherence to insulin-treatment and glucose monitoring.”
BackgroundSingh, V., Jhingan, A. K., Dahiya, S., & Kumari, G. (2018) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.6.1.07 · Cited by 41
Simonson, D. C., Vernon, A., Foster, K., Halperin, F., Patti, M. E., & Goldfine, A. B. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.03.038 · Cited by 30
Deerochanawong, C., Chan, S. P., Matawaran, B. J., Sheu, W. H., Chan, J. C. N., Man, N. H., Suastika, K., Khoo, C. M., Yoon, K., Luk, A. O. Y., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13819 · Cited by 31
Wang, P., Ma, X. M., Geng, K., Jiang, Z. Z., Yan, P. Y., & Xu, Y. (2022) · Phytotherapy Research · doi:10.1002/ptr.7572 · Cited by 31
“Despite this potential benefit, many T2D patients do not have the best control of cardiovascular risk factors (Ali et al., 2013; Walraven et al., 2015).”
BackgroundJiang, F., Hou, X., Lü, J., Zhou, J., Lu, F., Kan, K., Tang, J., Bao, Y., & Jia, W. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0289 · Cited by 30
“After the exclusion of 39 subjects with A1CNow + values over 13% (i.e., outside the reportable range of A1CNow + measurements [4–13%]), 1,618 patients with diabetes (1,274 out-patients and 344 inpatients) were included in the study.”
Sacre, J. W., Harding, J. L., Shaw, J. E., & Magliano, D. J. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyaa270 · Cited by 32
Multiple long-term conditions as the next transition in the global diabetes epidemic
Gregg, E. W., Holman, N., Sophiea, M. K., Misra, S., Pearson‐Stuttard, J., Valabhji, J., & Khunti, K. (2025) · Communications Medicine · doi:10.1038/s43856-025-00742-9 · Cited by 35
Self-citationPharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes
Howard-Thompson, A., Farland, M. Z., Byrd, D. C., Airee, A., Thomas, J., Campbell, J., Cassidy, R., Morgan, T., & Suda, K. J. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013504738 · Cited by 34
Triplitt, C. L., Solis‐Herrera, C., Cersósimo, E., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1114098 · Cited by 33
Grant, R. W., Uratsu, C. S., Estacio, K. R., Altschuler, A., Kim, E. S., Fireman, B. H., Adams, A. S., Schmittdiel, J. A., & Heisler, M. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.01.012 · Cited by 31
Tutino, G., Yang, W., Li, X., Li, W. H., Zhang, Y. Y., Guo, X. H., Luk, A. O. Y., Yeung, R. O., Yin, J., Ozaki, R., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13164 · Cited by 29
Metabolic surgery for type II diabetes: an update
Gentileschi, P., Bianciardi, E., Benavoli, D., & Campanelli, M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01722-w · Cited by 40
Liu, H., Wang, F., Liu, X., Xie, Y., Xia, H., Wang, S., & Sun, G. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01630-0 · Cited by 37
“Approximately 80% of T2DM patients in the USA suffer from dyslipidemia [4].”
BackgroundA calibration approach to transportability and data‐fusion with observational data
Josey, K., Yang, F., Ghosh, D., & Raghavan, S. (2022) · Statistics in Medicine · doi:10.1002/sim.9523 · Cited by 44
“We also examined the scenario which combines the 2004 to 2009 sample with the 2010 to 2014 sample to estimate the risk difference among patients in the 2010 to 2014 cohort using (14) to (16), which accommodates the data-fusion setting.”
BackgroundMethodInfluentialHow are qualitative methods used in diabetes research? A 30-year systematic review
Hennink, M. M., Kaiser, B. N., Sekar, S., Griswold, E. P., & Ali, M. K. (2017) · Global Public Health · doi:10.1080/17441692.2015.1120337 · Cited by 28
Self-citationKibirige, D., Chamba, N. G., Biraro, I. A., Kilonzo, K., Laizer, S. N., Sekitoleko, I., Kyazze, A. P., Ninsiima, S., Ssekamatte, P., Bongomin, F., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-060786 · Cited by 34
Thewjitcharoen, Y., Yenseung, N., Malidaeng, A., Nakasatien, S., Chotwanvirat, P., Krittiyawong, S., Wanothayaroj, E., & Himathongkam, T. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0297-y · Cited by 33
“Unfortunately, more than 50–70% of patients with type 2 diabetes mellitus (T2DM) failed to achieve optimal glycemic control [2, 3].”
BackgroundHenry, R. R., Rosenstock, J., Denham, D. S., Prabhakar, P., Kjems, L., & Baron, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1519 · Cited by 31
“Over 50%of patients with type 2 diabetes (T2D) have inadequate glycemic control (1,2) despite the availability of an increas-”
BackgroundVo, M., Uratsu, C. S., Estacio, K. R., Altschuler, A., Kim, E., Alexeeff, S., Adams, A. S., Schmittdiel, J. A., Heisler, M., & Grant, R. W. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4756-4 · Cited by 29
Siaw, M. Y. L., Malone, D. C., Ko, Y., & Lee, J. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12700 · Cited by 29
Carretero‐Gómez, J., Arévalo‐Lorido, J. C., Gómez‐Huelgas, R., de Lucas, M. D. G., Polo, L. M., Aguilar, J. M. V., Ripoll, J. M. S., & Ena, J. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.09.001 · Cited by 30
Xu, R., Xing, M. J., Javaherian, K., Peters, R. M., Ross, W. R., & Bernal‐Mizrachi, C. (2019) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2019.0035 · Cited by 33
Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30
Oser, T. K., Cucuzzella, M. T., Stasinopoulos, M., MONCRIEF, M. A., McCall, A. L., & Cox, D. J. (2022) · JMIR Diabetes · doi:10.2196/34465 · Cited by 27
“Further, glycemic control has not improved over the past decade [5-7].”
BackgroundMulti-organ denervation: a novel approach to combat cardiometabolic disease
Kiuchi, M. G., Carnagarin, R., Matthews, V. B., & Schlaich, M. P. (2023) · Hypertension Research · doi:10.1038/s41440-023-01287-x · Cited by 27
Heinemann, L., Schramm, W., Koenig, H., Moritz, A., Vesper, I., Weissmann, J., & Kulzer, B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819867686 · Cited by 28
Treatment and practical considerations of diabetic kidney disease
Bilen, Y., Almoushref, A., Alkwatli, K., Osman, O., Mehdi, A., & Sawaf, H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1264497 · Cited by 29
“Trials have shown that these agents slow the progression of moderately increased albuminuria to overt proteinuria and even prevent the development of albuminuria in normotensive patients with no albuminuria (8–12).”
BackgroundRace and Referral to Diabetes Education in Primary Care Patients With Prediabetes and Diabetes
Hooks-Anderson, D. R., Crannage, E. F., Salas, J., & Scherrer, J. F. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715574604 · Cited by 27
Buysman, E. K., Chow, W. S., Henk, H. J., & Rupnow, M. F. T. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.982750 · Cited by 26
Goltsman, D., Morrison, K. A., & Ascherman, J. A. (2017) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001461 · Cited by 31
McBrien, K., Manns, B., Hemmelgarn, B. R., Weaver, R. G., Edwards, A. L., Ivers, N. M., Rabi, D. M., Lewanczuk, R. Z., Braun, T., Naugler, C. T., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.13023 · Cited by 33
Recent Trends in Diabetes Knowledge, Perceptions, and Behaviors
Piccinino, L. J., Griffey, S., Gallivan, J. M., Lotenberg, L. D., & Tuncer, D. M. (2015) · Health Education & Behavior · doi:10.1177/1090198115577373 · Cited by 26
Pumerantz, A. S., Bissett, S. M., Dong, F., Ochoa, C., Wassall, R. R., Dávila, H. H., Barbee, M., Nguyen, J. V. L., Vila, P., & Preshaw, P. M. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000413 · Cited by 29
“known diabetes have annual dental examinations.(13) In the UK, despite 15 Healthcare Essentials that comprise the most recent guidelines for care for everyone with diabetes published by Diabetes UK, periodontal health is not included and there is no recommendation to seek oral health evaluation.”
BackgroundKim, D., Li, A. A., Cholankeril, G. T., Kim, S. H., Ingelsson, E., Knowles, J. W., Harrington, R. A., & Ahmed, A. (2019) · Diabetologia · doi:10.1007/s00125-019-4870-9 · Cited by 27
Inadequacies of current approaches to prediabetes and diabetes prevention
Bergman, M. (2013) · Endocrine · doi:10.1007/s12020-013-0017-9 · Cited by 26
Translating What Works: A New Approach to Improve Diabetes Management
Phillips, L. S., Barb, D., Yong, C., Tomolo, A. M., Jackson, S. L., Olson, D. E., Rhee, M. K., Duva, I. M., He, Q., & Long, Q. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815576000 · Cited by 25
Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease
Zonszein, J., & Groop, P. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0208-5 · Cited by 32
“Despite the number of treatment options, hyperglycemia is still often poorly controlled [3], chiefly reflecting the limitations inherent in treatment options for T2DM and clinical inertia.”
BackgroundQuality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry ®
Arnold, S. V., Goyal, A., Inzucchi, S. E., McGuire, D. K., Tang, F., Mehta, S. N., Sperling, L. S., Maddox, T. M., EINHORN, D. F., Wong, N. D., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005999 · Cited by 26
Koloverou, E., & Panagiotakos, D. B. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.6 · Cited by 27
Gregg, E. W. (2017) · Diabetes Care · doi:10.2337/dci16-0055 · Cited by 26
“were paralleled by large improvements in risk factor management and processes of care during the 2000s, as the proportion of adults meeting recommended targets improved by 9, 12, and 21 percentage points for glycemic control, blood pressure, and lipid control, respectively (36).”
BackgroundMethodSelf-citationKuo, C., Chen, Y., Hsu, C., Chang, C. C., Chou, R., Li, S., Kuo, S., Huang, P., Chen, J., & Lin, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016179 · Cited by 27
“Diabetes is also the leading cause of chronic kidney disease (CKD) and end-stage renal disease.(4) Convincing evidence has shown that an inter-relationship between chronic inflammation and metabolic abnormalities in diabetes leads to endothelial dysfunction and vascular complications.”
BackgroundWilliamson, C. R., Glauser, T. A., Burton, B. S., Schneider, D., Dubois, A. M., & Patel, D. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2764 · Cited by 26
Thayer, S., Chow, W. S., Korrer, S., & Aguilar, R. B. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1159954 · Cited by 24
“Patients were then assigned to one of two study cohorts: (1) patients who had an index pharmacy claim of CANA (CANA cohort); and (2) patients who had an index pharmacy claim of a DPP-4 inhibitor (DPP-4 inhibitor cohort).”
MethodDisparities in mortality among adults with and without diabetes by sex and race
Mansour, O., Golden, S. H., & Yeh, H. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107496 · Cited by 25
Gosmanov, A. R., Lü, J., Sumida, K., Potukuchi, P. K., Rhee, C. M., Kalantar‐Zadeh, K., Molnar, M. Z., & Kovesdy, C. P. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000864 · Cited by 25
“Also, several studies demonstrated ethnic/racial disparities in cardiovascular risk factor control in diabetes [27, 28, 37].”
BackgroundResultInfluentialBain, S. C., Feher, M. D., Russell-Jones, D. L., & Khunti, K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12760 · Cited by 27
“0% (64 mmol/mol), respectively.(42) Among patients in the Swedish National Diabetes Register with type 2 diabetes and no history of coronary heart disease, 78.”
BackgroundCambra, K., Galbete, A., Forga, L., Lecea, Ó., Ariz, M. J., Moreno-Iribas, C., Aizpuru, F., & Ibáñez, B. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0533-9 · Cited by 25
“%) was between 8 and 30 percentage points higher than those found in other European countries, but it was 10 percentage points lower than those reported in Canada, and in the USA from the National Health and Nutrition Examination Survey (NANHES) [21, 23, 24].”
ResultObesity: the real pandemic of the 21st century
Villalobos, J. Á. C. (2016) · Cirugía y Cirujanos (English Edition) · doi:10.1016/j.circen.2016.08.013 · Cited by 24
van Herpt, T. T. W., Lemmers, R. F. H., van Hoek, M., Langendonk, J. G., Erdtsieck, R. J., Bravenboer, B., Lucas, A. E. M., Mulder, M. T., Haak, H. R., Lieverse, A. G., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0245-x · Cited by 28
Fazio, S., Edwards, J., Miyamoto, S., Henderson, S., Dharmar, M., & Young, H. M. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.08.028 · Cited by 31
Aschner, P. J., Galstyan, G. R., Yavuz, D. G., Litwak, L., González-Gálvez, G., Eliaschewitz, F. G., Hafidh, K., Djaballah, K., Tu, S., Unnikrishnan, A., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-00997-0 · Cited by 27
“glycemic control in that sub-analysis, 63% in patients with diabetes duration between 5 and 12 years, was higher than that observed in the NHANES survey in the USA [15] and in the GUIDANCE study in European countries [16] (Fig.”
MethodResultInfluentialMagee, M. F., Nassar, C. M., Mete, M. Y., White, K., Youssef, G. A., & Dubin, J. S. (2015) · Endocrine Practice · doi:10.4158/ep15655.or · Cited by 23
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies
Linskey, D. W., Linskey, D. C., McLeod, H. L., & Luzum, J. A. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0108 · Cited by 23
Aronson, R., Orzech, N., Ye, C., Brown, R. E., Goldenberg, R., & Brown, V. (2016) · Diabetes Care · doi:10.2337/dc15-2666 · Cited by 23
Holland‐Carter, L., Tuerk, P. W., Wadden, T. A., Fujioka, K., Becker, L. E., Miller‐Kovach, K., Hollander, P. L., Garvey, W. T., Weiß, D., Rubino, D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.022 · Cited by 51
Ruiz, P. L., Bakken, I. J., Håberg, S. E., Tapia, G., Hauge, S. H., Birkeland, K. I., Gulseth, H. L., & Stene, L. C. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12984 · Cited by 23
Fortmann, A. L., Walker, C., Barger, K., Robacker, M., Morrisey, R., Ortwine, K., Loupasi, I., Lee, I., Hogrefe, L., Strohmeyer, C., et al. (2020) · Population Health Management · doi:10.1089/pop.2019.0103 · Cited by 27
“The current health care model too often fails to assure that patients receive effective interventions.(4) As a result, diabetes care is often poorly coordinated, and many individuals show inadequate clinical control, which in turn diminishes quantity and quality of life.”
BackgroundBlindbæk, S. L., Schlosser, A., Green, A., Holmskov, U., Sørensen, G. L., & Grauslund, J. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0953-y · Cited by 23
“Unfortunately, high proportions of people with diabetes are unable to meet the recommended standards of diabetes care [8, 9].”
BackgroundRole of lipid-lowering agents in the management of diabetic retinopathy
Ioannidou, E., Tseriotis, V., & Τζιόμαλος, Κ. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i1.1 · Cited by 25
Professional flash continuous glucose monitoring as a supplement to A1C in primary care
Hirsch, I. B. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1383137 · Cited by 25
Screening for Diabetes Risk Using Integrated Dental and Medical Electronic Health Record Data
Acharya, A., Cheng, B., Koralkar, R., Olson, B., Lamster, I. B., Kunzel, C., & Lalla, E. (2018) · JDR Clinical & Translational Research · doi:10.1177/2380084418759496 · Cited by 29
Lee, J., Moon, J. S., Kang, D. R., Lee, S. J., Son, J., Youn, Y. J., Ahn, S. G., Ahn, M., Kim, J., Yoo, B., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020505 · Cited by 23
“demonstrated that one third to half of diabetic patients did not reach the target goal of blood sugar level, optimal blood pressure, or low-density lipoprotein (LDL)-cholesterol level [24].”
BackgroundToffanin, C., Magni, L., & Cobelli, C. (2021) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2021.3075775 · Cited by 22
“It has been estimated that only about half of the patients meet the targets recommended by the scientific societies clinical guidelines [6] despite the exorbitant number of therapeutic actions (100.”
BackgroundHeo, J. H., Han, K. A., Hong, J. H., Seo, H.-A., Hong, E., Yu, J. M., Jung, H. S., & Soo, B. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0314 · Cited by 26
“Globally, only approximately 50% of people with diabetes have achieved the target HbA1c level of 7% [13,14].”
BackgroundIkeda, N., Nishi, N., Noda, H., & Noda, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.011 · Cited by 23
Screening and Treatment by the Primary Care Provider of Common Diabetes Complications
Gilbert, M. P. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.002 · Cited by 27
Wong, H. K., Ong, K. L., Cheung, C., & Cheung, B. M. Y. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.05.001 · Cited by 23
“A recent study has also shown that about 33%e48% of subjects with diabetes did not meet the targets for glycemic, blood pressure, or low-density lipoprotein (LDL) cholesterol control in US NHANES, 1999e2010 [7].”
BackgroundFung, C. S. C., Wan, E. Y. F., Jiao, F., & Lam, C. L. K. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0072-x · Cited by 23
Vejle Diabetes Biobank – a resource for studies of the etiologies of diabetes and its comorbidities
Petersen, E. R. B., Nielsen, A. A., Christensen, H., Hansen, T. F., Pedersen, O. B., Christensen, C., & Brandslund, I. (2016) · Clinical Epidemiology · doi:10.2147/clep.s113419 · Cited by 22
“Variable Median (25–75 quartiles) unless stated otherwise Type 2 diabetes (T2D) patients Type 1 diabetes (T1D) patients Control population Missing na (T2D/ T1D/control population) Enrolled, n 2,721 599 4,255 Sex, n (%) Female Male 1,052 (39) 1,669 (61) 234 (39) 365 (61) 1,873 (44) 2,382 (56) Age, December 31, 2006 (ye…”
Carretero‐Gómez, J., Arévalo‐Lorido, J. C., Huelgas, R. G., Vidal, M. T. S., Tembra, M. S., Aguilar, J. M. V., Voces, I. M., Pérez, E. F., Rodríguez, J. M. F., & Muñoz, J. E. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.11.003 · Cited by 24
Hirsch, I. B., & Verderese, C. A. (2017) · Endocrine Practice · doi:10.4158/ep171962.ra · Cited by 22
Deseive, S., Straub, R., Kupke, M., Broersen, A., Kitslaar, P., Stocker, T., Massberg, S., Hadamitzky, M., & Hausleiter, J. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2018.09.008 · Cited by 24
Trends and risk factors in severe hypoglycemia among individuals with type 2 diabetes in Korea
Lee, S. E., Kim, K., Son, K. J., Song, S. O., Park, K. H., Park, S. H., & Nam, J. Y. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108946 · Cited by 25
Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
Tsujimoto, T., Kajio, H., & Sugiyama, T. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13039 · Cited by 22
“Patients with diabetes have reportedly become more successful in controlling their risk factors and have improved adherence to preventive practices.(10) Moreover, rates of diabetes-related complications have declined in the past 2 decades.”
BackgroundNovel determinants preventing achievement of major cardiovascular targets in type 2 diabetes
Camara, S., Bouénizabila, E., Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.037 · Cited by 22
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
Raskin, P., & Mann, K. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s35331 · Cited by 26
“the introduction of the thiazolidinediones, most treatments have been inadequate, with almost one half of patients with diabetes having glycated hemoglobin (HbA 1c ) levels above accepted targets.(14) It is clear that what was needed were agents or greater use of combinations of agents that directly target the multipl…”
BackgroundBardenheier, B. H., Lin, J., Zhuo, X., Ali, M. K., Thompson, T. J., Cheng, Y. J., & Gregg, E. W. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30090-0 · Cited by 25
“population, our findings are consistent with the concurrent improvements in the management and control of cardiovascular disease risk factors and HbA1c as well as improved processes of care and reductions in diabetes-related complications and other chronic conditions, such as cardiovascular disease.(13-15) The decreas…”
Self-citationAndrews, S. M., Sperber, N. R., Gierisch, J. M., Danus, S. M., Macy, S., Bosworth, H. B., Edelman, D. E., & Crowley, M. J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s125673 · Cited by 22
“1 year, despite clinic-based care,(5) contribute disproportionately to the nationwide diabetes burden.(6,7) The prevalence of PPDM is ~10% of US adults with diabetes.”
Morgan, P., Everett, C. M., Smith, V. A., Woolson, S., Edelman, D. E., Hendrix, C. C., Berkowitz, T. S. Z., White, B. S., & Jackson, G. L. (2017) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/0046958017712762 · Cited by 23
Harris, S. B., Abrahamson, M. J., Ceriello, A., Charpentier, G., Evans, M., Lehmann, R., Liebl, A., Linjawi, S., Holt, R. I. G., Hosszúfalusi, N., et al. (2020) · Drugs · doi:10.1007/s40265-019-01245-3 · Cited by 22
Kwan, B. M., Dickinson, L. M., Glasgow, R. E., Sajatovic, M., Gritz, M., Holtrop, J. S., Nease, D. E., Ritchie, N. D., Nederveld, A., Gurfinkel, D., et al. (2020) · Trials · doi:10.1186/s13063-019-3938-7 · Cited by 23
Anjana, R. M., Deepa, M., Subashini, R., Patel, S. A., Kondal, D., Ranjit Unnikrishnan, I., Tandon, N., Prabhakaran, D., Narayan, K. M. V., Kadir, M. M., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14424 · Cited by 21
Self-citationLithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc13-2023 · Cited by 21
Osborn, C. Y., Mayberry, L. S., & Kim, J. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12360 · Cited by 25
Swoboda, P., McDiarmid, A. K., Erhayiem, B., Haaf, P., Kidambi, A., Fent, G. J., Dobson, L. E., Musa, T. A., Garg, P., Law, G. R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1318 · Cited by 21
Personalised treatment targets in type 2 diabetes patients: The Dutch approach
Boels, A. M., Hart, H. E., Rutten, G. E., & Vos, R. C. (2017) · Primary Care Diabetes · doi:10.1016/j.pcd.2016.08.001 · Cited by 20
Malta, D. C., Ribeiro, E. G., Gomes, C. S., Alves, F. T. A., Stopa, S. R., Sardinha, L. M. V., Pereira, C. A., Duncan, B. B., & Schmidt, M. I. (2022) · Epidemiologia e Serviços de Saúde · doi:10.1590/ss2237-9622202200011.especial · Cited by 25
Jiménez‐Trujillo, I., Jiménez‐García, R., Esteban‐Hernández, J., Hernández‐Barrera, V., Carrasco‐Garrido, P., Salinero-Fort, M. Á., Cárdenas‐Valladolid, J., & López‐de‐Andrés, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131844 · Cited by 20
“Studies conducted in other countries find adherence levels for these two preventive practices that are similar to ours [11,12, 38, 39].”
BackgroundMethodResultInfluentialNeslusan, C. A., Teschemaker, A. R., Johansen, P., Willis, M. S., Valencia-Mendoza, A., & Puig, A. (2015) · Value in Health Regional Issues · doi:10.1016/j.vhri.2015.01.002 · Cited by 23
“[9] Ali MK, Bullard KM, Saaddine JB, et al.”
Background
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.